NCT01759771View on ClinicalTrials.gov

Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 3, 2013

Primary Completion Date

October 18, 2018

Study Completion Date

May 11, 2020

Conditions
Prostate Cancer
Interventions
DRUG

Vitamin D3

4,000 IU of VD3 for at least one year

DRUG

Placebo

Placebo for at least one year

Trial Locations (2)

29425

Medical University of South Carolina, Charleston

29401-5799

Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston

All Listed Sponsors
collaborator

Medical University of South Carolina

OTHER

lead

VA Office of Research and Development

FED

NCT01759771 - Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial | Biotech Hunter | Biotech Hunter